Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

King Moves Sales & Marketing To N.J.; Andrzejewski Will Head Commercial Operations

This article was originally published in The Pink Sheet Daily

Executive Summary

The new location will enhance King's sales and marketing capabilities, the company says. Former Schering-Plough and Endo exec Steve Andrzejewski will oversee the new office.

King is moving its sales and marketing operations to Princeton, N.J., the company announced May 27.

The Bristol, Tenn.-based company will be transferring fewer than 10 people to New Jersey, but plans on hiring over 40 to support the new operation.

King hopes that the move - and expanded team - will enhance its sales and marketing capabilities

The Princeton office will be overseen by Steve Andrzejewski who joined the company in mid-May as head of commercial operations.

Andrzejewski will be responsible for King's sales, marketing and managed care activities.

The appointment coincides with the elevation of Chief Operating Officer Brian Markison to acting president and CEO (1 (Also see "King Names Markison Acting CEO; President Macione Steps Down" - Pink Sheet, 18 May, 2004.)).

Prior to joining King, Andrzejewski was senior VP-commercial business for Endo. Prior to that, he served as VP-new products and VP-marketing for respiratory and anti-infective products at Schering-Plough from 1987 until 2003.

- John Rancourt

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel